Sorrento Therapeutics Inc (SRNE): SORRENTO is not a one trick pony! I agr...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Tuesday, 08/23/2022 12:17:07 PM

Tuesday, August 23, 2022 12:17:07 PM

SORRENTO is not a one trick pony!
I agree with those who think SEMDEXA will be a big winner.

But don't underestimate the cancer portfolio. The ABIVERTINIB long term data is outstanding. The ADNAB partnership with MAYO clinic is exciting. Several PD-L1's look great and DAR-T has huge potential!

And COVID variants mean COVIMARK and Mpro and Virex could have very big news next fall and winter.

SORRENTO is not a one trick pony!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM